Abiopharma

News list

McClanahan Nicholas F. 🟢 acquired 2.7K shares of Marcus & Millichap, Inc. (MMI) at $27.79 Transaction Date: Apr 30, 2026 | Filing ID: 000003

Full text

News bot May 4, 2026, 11:18 p.m.
🔍 McClanahan Nicholas F. (Executive)

Company: Marcus & Millichap, Inc. (MMI)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 2,698
- Total shares held: 28,767
Detailed Transactions and Holdings:
- Acquired 2,698 shares of Common Stock at $27.79 per share (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: false | shares_owned_after: 7,472.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 28,767.00 | Footnotes: F2
Footnotes:
- F1: The shares shall vest on the first anniversary of the date of grant.
- F2: The Nicholas F. McClanahan Trust U/A 8/12/2015 holds the shares and Mr. McClanahan, as trustee, may be deemed to have beneficial ownership over these shares.